Zink phosphide poisoning management

Reading File
Finding Sources
Finding Sources
Searching PubMed

"zinc phosphide" poisoning management

Reading File
Reading File
Reading Article
Reading Article
Reading File
Reading Article
Reading File
I now have comprehensive information. Let me compile the full detailed answer.

Zinc Phosphide (Zn₃P₂) Poisoning - Management

Overview

Zinc phosphide is a steel-grey crystalline powder with a garlic/fish-like odour. It is a widely used, cheap, and effective rodenticide and pesticide. Its primary danger is the generation of phosphine gas (PH₃) on contact with gastric acid or atmospheric moisture:
Zn₃P₂ + 6HCl → 3ZnCl₂ + 2PH₃↑
Fatal dose: ~5 grams Fatal period: A few hours to 24 hours LD₅₀: ~40 mg/kg

Mechanism of Toxicity

Phosphine inhibits Cytochrome C Oxidase (Complex IV) of the mitochondrial electron transport chain, disrupting cellular respiration - similar to cyanide. This results in:
  • Free radical generation and oxidative stress
  • Multi-organ dysfunction (heart, liver, kidney, lungs, CNS)
  • Cellular hypoxia despite adequate oxygen delivery
Key difference from aluminium phosphide (AlP): ZnP has a delayed onset of systemic symptoms due to slower phosphine release kinetics. It also has a higher propensity for acute liver failure early in the course.

Clinical Features

GI (early, within minutes to hours)

  • Metallic taste, burning in throat, oesophagus, stomach
  • Nausea, vomiting, diarrhoea, abdominal pain
  • Garlic/fish odour on breath and vomitus
  • Symptom-free interval possible before systemic effects

Cardiovascular

  • Bradycardia, sinus tachycardia, ECG abnormalities
  • Arrhythmias, heart block
  • Hypotension, cardiovascular collapse
  • Myocardial damage, pericarditis, congestive cardiac failure (rare)

Respiratory

  • Dyspnoea, pulmonary oedema, respiratory distress
  • Cyanosis (terminal)

Neurological

  • Agitation, excitement
  • Hypocalcaemia, tetany, convulsions, coma

Other

  • Oliguria, renal failure
  • Metabolic acidosis
  • Hepatotoxicity / acute liver failure
  • Haemorrhages, bleeding diathesis
  • Shock

Diagnosis

Clinical: Garlic/fishy odour on breath + history of exposure + multi-organ failure.
Silver nitrate paper test: Patient breathes on filter paper impregnated with 0.1 N silver nitrate for 5-10 minutes. Blackening = positive (phosphine reduces silver nitrate to metallic silver).
Post-mortem findings: Petechial haemorrhages in skin, garlic odour on opening stomach, greyish-black residue sticking to gastric mucosa, congestion of liver/spleen/kidney/brain/lungs, necrobiosis of liver.

Management

1. Decontamination (Priority - Before Absorption)

Skin/eyes: Remove contaminated clothing immediately; wash thoroughly with soap and water.
GI decontamination (critical window - do early):
  • Induced vomiting: 1 tablespoon of salt in warm water, repeated until vomiting fluid is clear
  • Gastric lavage with 3-5% sodium bicarbonate solution - alkaline pH minimises the conversion of zinc phosphide to phosphine gas. Also, 1% copper sulphate or 1% potassium permanganate, or mineral oil (coconut/liquid paraffin) can be used - these convert the compound to phosphate within ~30 minutes and reduce phosphine absorption
    • Note: Some recent studies caution against gastric lavage because added moisture accelerates phosphine generation; this remains debated
  • Activated charcoal: May be considered, though evidence is limited
Important: Zinc phosphide adheres firmly to the crypts of the gastric mucosa. Even small residual amounts after lavage can cause death by slow absorption. Extended observation is mandatory even after apparent initial recovery. - Parikh's Textbook of Medical Jurisprudence

2. Supportive Care (Cornerstone of Management)

There is no specific antidote for zinc phosphide poisoning.
ComplicationIntervention
Respiratory distress / pulmonary oedemaOxygen inhalation, mechanical ventilation (IPPV), steroids
Cardiovascular collapse / arrhythmiasMagnesium sulphate IV (3 g bolus, then 6 g over 24 hours for 5-7 days); low-dose dopamine infusion
Hypocalcaemia / tetanyIV calcium salts
Metabolic acidosisSodium bicarbonate 50 mEq IV every 15 min until arterial bicarbonate >15 mmol/L
InfectionBroad-spectrum antibiotics
Hepatic injuryLiver-targeted supportive therapy (N-acetylcysteine; see below)
Haemorrhage / coagulopathyVitamin K
SeizuresBenzodiazepines, sedatives
Refractory shockECMO (evidence from AlP studies; applicable to ZnP)

3. Antioxidant / Adjunct Therapies (Emerging Evidence)

Based on evidence from aluminium phosphide poisoning (mechanism largely shared) and direct ZnP studies:
  • N-Acetylcysteine (NAC): Meta-analysis of RCTs (OR 3.97, 95% CI 1.69-9.30 for recovery; OR 0.25 for mortality reduction) - significant benefit. Replenishes glutathione, reduces oxidative injury, directly supports hepatic recovery (especially relevant in ZnP's propensity for acute liver failure). [PMID: 34455951]
  • Vitamin E: Antioxidant; shown to reduce mortality in AlP clinical studies
  • Glucose-Insulin-Potassium (GIK) infusion: Myocardial protective
  • Fresh packed RBCs: Used in some centres with reported benefit
  • Magnesium sulphate: Anti-arrhythmic and membrane-stabilising; standard adjunct

4. Proposed ZnP-Specific Protocol (Faress et al., 2025)

A 2025 review (PMID: 41768810) proposes a protocol specifically for zinc phosphide - emphasising:
  1. Aggressive GI decontamination first (due to delayed symptom onset giving a longer therapeutic window vs. AlP)
  2. Early targeted treatment for acute hepatic failure (ZnP has higher liver failure risk than AlP)
  3. Application of existing AlP management protocols for systemic phosphine toxicity once absorption occurs

5. Advanced Life Support

  • ECMO (Extracorporeal Membrane Oxygenation): For refractory cardiovascular failure, supported by evidence from AlP poisoning cases; should be considered early in severely poisoned patients
  • ICU admission for all symptomatic patients
  • Continuous ECG monitoring

Special Considerations

  • Observe for delayed symptoms even after initial recovery - ZnP binds to gastric mucosa and can be absorbed slowly
  • Healthcare workers must avoid inhaling vomitus or gastric contents (phosphine off-gassing risk)
  • Rooms where patients are managed should be ventilated
  • No specific antidote exists - management remains supportive; evidence-based standardised protocols are still lacking per 2023 systematic review [PMID: 37387512]

Key Evidence

SourceFindings
Parikh's Textbook of Medical JurisprudenceGastric lavage with NaHCO₃, emesis, Vit K, corticosteroids, supportive care
Dikshit's Textbook of Forensic MedicineNaHCO₃/KMnO₄/CuSO₄ lavage; MgSO₄ IV, calcium, steroids, dopamine, O₂
Sobh ZK et al. (2023) - Systematic Review [PMID: 37387512]79 treatment modalities reviewed; ECMO, NAC, Vit E, GIK, RBCs, GI decontamination with oils shown to reduce mortality; no antidote or standardised protocol yet
Rashid M et al. (2022) - Meta-Analysis [PMID: 34455951]NAC significantly reduces mortality (OR 0.25) and improves recovery in rodenticide poisoning
Faress F et al. (2025) - Review [PMID: 41768810]First ZnP-specific protocol proposed; aggressive decontamination + hepatic treatment + AlP protocols for systemic phosphine
This is a shared conversation. Sign in to Orris to start your own chat.